Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...

Gilead Sciences is the first and so far only company ... He also suggested there might be some shortcomings in the design, for example a lack of confirmation of COVID-19 infection at enrolment ...

ObvioHealth, a global leader in digital clinical trial solutions, announces the appointment of Richard Watkins as Chief Revenue Officer (CRO). With over 20 years of experience in sales leadership, ...

REDWOOD CITY, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ADVM), a company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today announced ...

Start Campus, a company focused on designing, building and operating a new generation of sustainable data centers and JetCool, a leading provider of advanced liquid cooling technology, announced today ...

Fintel reports that on October 21, 2024, Leerink Partners upgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from ...

Leerink upgraded Gilead (GILD) to Outperform from Market Perform with a price target of $96, up from $74. The stock has appreciated following ...

Leerink has upgraded Gilead Sciences (GILD) to outperform, citing the growth outlook for its PrEP medication lenacapavir for ...

As you can see from the chart above the percentage of shares that are sold short for Gilead Sciences has declined since its ...

TD Cowen analyst Tyler Van Buren has maintained their bullish stance on GILD stock, giving a Buy rating today. Tyler Van Buren’s rating ...